Definium Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -67,265 | -42,744 | -23,348 | -34,741 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,567 | -29,599 | -29,419 | -25,351 |
Cash | 19,959 | 33,392 | 82,854 | 273,741 |
Basic Shares | 76,774 | 75,803 | 75,511 | 75,100 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -108,679 | -95,732 | -56,796 | -93,036 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -79,129 | -64,365 | -50,139 | -45,824 |
Cash | 273,741 | 99,704 | 142,142 | 133,539 |
Basic Shares | 75,100 | 41,101 | 37,979 | 28,096 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.78 |
2025-06-30 | -$0.50 |
